Dean Hatt
Dean joined Broughton having enjoined a successful career in the pharmaceutical industry with over 30 years of experience with GlaxoSmithKline. He has extensive expertise in in vitro and in vivo drug delivery including inhalation and drug development of both new chemical entities and biologicals.
Recent Posts
A Summary of DDL 2022
December 13, 2022
Day 1 of DDL opened with Federico Lavorini’s history and future of drug delivery, and it was a lively presentation… the perfect inhaler was ...